Document:

Exhibit
10.11

 

EXECUTION
VERSION

 

EQUITY
CONTRIBUTION AGREEMENT

 

This
Equity Contribution Agreement (this “Agreement”)
is entered into effective as of February 2, 2021, by and among Banco Invex, S.A., Institución de Banca Múltiple, Invex
Grupo Financiero acting solely and exclusively as trustee pursuant to the Contrato de Fideicomiso Irrevocable de Emisión de
Certificados Bursátiles Fiduciarios de Desarrollo Número F/2416 identified as “LIV Mexico Growth IV No. F/2416”
(the “CKD”) and LIV Mexico Growth Fund IV, L.P. (the “LIV LP” and, together with
CKD, each, an “Equity Investor” and collectively, the “Equity Investors”), LIV
Capital Acquisition Corp., a Cayman Islands exempted company (“LIVK”)
and AgileThought, Inc., a Delaware corporation (the “Company”).
The Equity Investors, LIVK and the Company are collectively referred to herein as the “Parties.”

 

RECITALS

 

A. Each
Equity Investor is an affiliate of LIVK. LIVK is a blank check company formed for the purpose of entering into a merger, share exchange,
asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses
or entities.

 

B. On
December 13, 2019, LIVK consummated its initial public offering of 7,000,000 units (the “Units” and, with respect
to the Class A ordinary shares of LIVK included in the Units sold, the “Public Shares”) at $10.00 per Unit,
pursuant to the Registration Statement on Form S-1 (File No. 333-234799) filed with the U.S. Securities and Exchange Commission.

 

C. On
November 25, 2020, LIVK and the Company entered into a non-binding (except as expressly set forth therein) letter agreement attached
hereto as Exhibit 1 (the “Business Combination LOI”) with respect to a proposed business combination
involving the Company and LIVK in which, among other things, LIVK will issue Public Shares (or shares of common stock of LIVK into which
such Public Shares are converted in connection with the domestication of LIVK as a Delaware corporation) (collectively, the “Post-Closing
Public Shares”) to the equityholders of the Company and the Company will become a wholly-owned subsidiary of LIVK, which
will remain a publicly-traded company trading on the Nasdaq Stock Market or another stock exchange or marketplace approved by the Company
and LIVK (the “Proposed Transaction”).

 

D. In
connection with the Proposed Transaction and as contemplated by the Business Combination LOI, (i) the Company, LIVK and a wholly owned
direct subsidiary of LIVK intend to enter into an Agreement and Plan of Merger setting forth the definitive terms and conditions of the
Proposed Transaction (the “Merger Agreement”), (ii) the Company, LIVK, certain of their affiliates and/or certain
other persons intend to enter into other documentation referred to in the Business Combination LOI and the Merger Agreement and (iii)
LIVK expects to obtain PIPE commitments from certain investors substantially on the terms and conditions set forth in the form of PIPE
Subscription Agreement attached hereto as Exhibit 2 (the “PIPE Subscription Agreements”).

 

     

     

    

 

E. Each
Equity Investor has agreed to make a capital investment in the Company on the terms and conditions set forth in this Agreement, including
in the Equity Investment Term Sheet attached hereto as Exhibit 3 (the “Equity Term Sheet”).

 

F. Concurrently
with the execution hereof, (i) the Company and the other necessary parties to the Senior Credit Agreement (as defined below) are entering
into a Waiver and Third Amendment to Amended and Restated Credit Agreement in the form attached hereto as Exhibit 4 (the
“Senior Lender Waiver”) and (ii) the Company and the other necessary parties to the Junior Credit Agreement
(as defined below) are entering into a Waiver and Second Amendment to First Amended and Restated Credit Agreement in the form attached
hereto as Exhibit 5 (the “Junior Lender Waiver”).

 

NOW,
THEREFORE, in consideration of the premises set forth above, the respective representations, warranties, covenants and agreements set
forth in this Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the Parties, intending to be legally bound, hereby agree as follows:

 

AGREEMENT

 

1. Certain
Definitions. As used herein, the following terms shall have the following meanings:

 

(a) “Junior
Credit Agreement” means that certain First Amended and Restated Credit Agreement, dated as of January 30, 2020, by and
among the Company and certain entities affiliated with the Company as borrowers, on the one hand, and certain financial institutions
as lenders and an administrative agent for the lenders and a collateral agent, on the other hand, as amended, restated, supplemented
or otherwise modified from time to time.

 

(b) “Senior
Credit Agreement” means that certain Amended and Restated Credit Agreement, dated as of July 18, 2019, by and among the
Company and certain entities affiliated with the Company as borrowers, on the one hand, and certain financial institutions as lenders
and an administrative agent for the lenders, on the other hand, as amended, restated, supplemented or otherwise modified from time to
time.

 

(c) “Non-Recourse
Party” means any person or entity other than each Equity Investor, LIVK and the Company. Without limiting the generality
of the foregoing, the term “Non-Recourse Party” means and includes: the former, current and future equity holders,
controlling persons, directors, officers, employees, agents, affiliates, members, managers, general or limited partners, or assignees
of each Equity Investor, LIVK, the Company or any former, current or future equity holder, controlling person, director, officer, employee,
agent, affiliate, member, manager, general or limited partner, or assignee of any of the foregoing (other than each Equity Investor,
LIVK, or the Company).

 

    2

     

    

 

2.
Capital Contribution.

 

2.1 Contribution.
Subject to the terms and conditions set forth herein, at the Closing, the Equity Investors shall collectively purchase (or shall cause
the purchase of, directly or indirectly), and the Company shall sell, issue and deliver to the Equity Investors, 2,000,000 shares of
a newly created class of Preferred Stock of the Company having the rights, preferences and privileges set forth in the Equity Term Sheet
(the “Shares”) at a purchase price of USD $10.00 per Share (the “Original Purchase Price”)
and for an aggregate purchase price equal to USD $20,000,0000 (the “Capital Contribution”). At least three
business days prior to the Closing, the Equity Investors shall notify the Company how the aggregate number of Shares to be sold hereunder
shall be individually allocated to each Equity Investor (and accordingly, how many Shares each Equity Investor will purchase at the Closing),
provided that the aggregate number of Shares to be purchased by all of the Equity Investors at the Closing shall equal 2,000,000.

 

2.2 Amendment
of Charter. The Company agrees that promptly following the date of this Agreement (but, in any event, prior to and as a condition
to the Closing) it will take all actions necessary or desirable to amend its certificate of incorporation to (i) create and authorize
the Shares and (ii) provide that the Shares will have the rights, preferences and privileges set forth in the Equity Term Sheet by adopting
and filing an amended and restated certificate of incorporation with the Secretary of State of the State of Delaware in a form mutually
agreed with the Equity Investors (the “Amended Charter”).

 

2.3 Use
of Proceeds. Promptly upon its receipt of the Capital Contribution at the Closing, the Company shall deliver the Capital Contribution
to one of its Mexican subsidiaries (A) as funding in connection with an intercompany loan or (B) in exchange for (i) a capital increase
or (ii) a future capital increase, in each case, pursuant to Mexican law. The Company shall deliver evidence of such intercompany loan
to or capital increase of one of its Mexican subsidiaries to the Equity Investors as soon as practicable, but, in any event, not later
than 45 (forty-five) business days after the date of the Closing. Once delivered to one of its Mexican subsidiaries, the Capital Contribution
will be used exclusively to invest or finance activities and projects of the Company and its subsidiaries in the Mexican territory, including
reducing the outstanding indebtedness of the Company and the other borrowers (one of which is a Mexican subsidiary of the Company) to
the lenders under the Senior Credit Agreement, and the Capital Contribution will not be used for any other purpose by the Company or
its subsidiaries.

 

2.4 Conditions.

 

(a) The
obligations of the Parties to consummate, or cause to be consummated, the transactions contemplated by this Agreement are subject to
the satisfaction, on or before the Closing, of each of the following conditions, unless otherwise waived (if permitted by applicable
law) in writing by all of the Parties:

 

(i) no
applicable governmental authority shall have enacted, issued, promulgated or entered any judgment, order, law, rule or regulation (whether
temporary, preliminary or permanent) which is then in effect and has the effect of making consummation of the transactions contemplated
hereby (including the Equity Investors’ capital call for purposes of their funding the Capital Contribution pursuant to this Agreement)
illegal or otherwise restraining or prohibiting consummation of the transactions contemplated hereby (including the Equity Investors’
capital call for purposes of their funding the Capital Contribution pursuant to this Agreement); provided, however, that the Equity
Investors agree to use commercially reasonable efforts to obtain all approvals from applicable governmental authorities necessary to
enable the Equity Investors to fund the Capital Contribution as and when required by this Agreement, and if the Equity Investors fail
to use such commercially reasonable efforts, the Equity Investors shall not be permitted to rely on the condition in this Section 2.4(a)(i)
as a basis for failing to fund the Capital Contribution and consummate the Closing;

 

    3

     

    

 

(ii) the
Senior Lender Waiver shall have been executed and delivered by the Company and the other necessary parties to the Senior Credit Agreement
and shall be in full force and effect, and a copy of the Senior Lender Waiver, as so executed and delivered, shall have been delivered
to the Equity Investors; and

 

(iii) the
Junior Lender Waiver shall have been executed and delivered by the Company and the other necessary parties to the Junior Credit Agreement
and shall be in full force and effect, and a copy of the Junior Lender Waiver, as so executed and delivered, shall have been delivered
to the Equity Investors; and

 

(iv) the
Company shall have adopted and filed the Amended Charter (for the avoidance of doubt, in a form mutually agreed with the Equity Investors)
with the Secretary of State of the State of Delaware on or prior to the Closing, which shall continue to be in full force and effect
as of the Closing.

 

(b) The
obligations of each Equity Investor to consummate, or cause to be consummated, the transactions contemplated by this Agreement are subject
to the satisfaction, on or before the Closing, of each of the following conditions, unless otherwise waived (if permitted by applicable
law) in writing by such Equity Investor:

 

(i) all
representations and warranties of the Company contained in Annex 3.1 to this Agreement shall be true and correct in all material respects
at and as of the Closing (other than representations and warranties that are qualified as to materiality or Material Adverse Effect (as
defined herein), which representations and warranties shall be true and correct in all respects), except, with respect to the representations
and warranties set forth in clauses (e) through (i) of Annex 3.1 to this Agreement, as set forth in the Disclosure Schedule and any supplement
thereto delivered by the Company to the Equity Investors pursuant to Section 4.5, and consummation of the Closing shall constitute a
reaffirmation by the Company of each of the representations, warranties, covenants and agreements of the Company contained in this Agreement
as of the Closing (as qualified by the Disclosure Schedule); and

 

(ii) the
Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by them at or prior to the Closing.

 

(c) The
obligations of the Company to consummate, or cause to be consummated, the transactions contemplated by this Agreement are subject to
the satisfaction, on or before the Closing, of each of the following conditions, unless otherwise waived (if permitted by applicable
law) in writing by the Company:

 

(i) all
representations and warranties of the Equity Investors contained in Annex 3.2 to this Agreement are true and correct in all material
respects at and as of the Closing, and consummation of the Closing shall constitute a reaffirmation by each Equity Investor of each of
the representations, warranties, covenants and agreements of such Equity Investor contained in this Agreement as of the Closing; and

 

    4

     

    

 

(ii) the
Equity Investors shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by them at or prior to the Closing.

 

2.5 Closing.
The Equity Investors agree to call the capital required to make the Capital Contribution as soon as practicable, but in any event no
more than five calendar days following the date of this Agreement. Subject to the terms and conditions set forth herein, the closing
of the transactions contemplated hereby, including the purchase, sale and issuance of the Shares as contemplated herein, shall occur
remotely via the exchange of documents and signatures, and the Capital Contribution required hereunder shall be made by wire transfer
to the Company (in accordance with wire instructions specified by the Company to the Equity Investors in writing at least three business
days prior to the Closing) of immediately available funds in U.S. dollars (collectively, the “Closing”). Subject
to the satisfaction of the terms and conditions of this Agreement, the Closing shall occur no later than March 22, 2021, and the Parties
shall use their best efforts to cause the Closing to occur as soon as possible after the date of this Agreement and prior to March 22,
2021. At the Closing, the Company shall deliver to each Equity Investor a certificate or notice of issuance (each of which may be in
electronic form) representing the Shares being purchased by such Equity Investor at the Closing.

 

2.6 Amendment
of Business Combination LOI. Notwithstanding anything to the contrary in the Business Combination LOI, LIVK and the Company agree
that the Business Combination LOI is hereby amended and restated to provide in its entirety in the form attached hereto as Exhibit
6 and that all references to “Business Combination LOI” in Sections 3 through 19 of this Agreement
and the Exhibits hereto shall be deemed to refer to the Business Combination LOI as so amended and restated.

 

3. Representations
and Warranties.

 

3.1 Representations
and Warranties of the Company. The Company represents and warrants to each Equity Investor that, except, with respect to the representations
and warranties set forth in clauses (e) through (i) of Annex 3.1 to this Agreement, as set forth in the Disclosure Schedule or in any
supplement to the Disclosure Schedule to be delivered by the Company to the Equity Investors pursuant to Section 4.5, (A) the representations
and warranties set forth in clauses (a) through (d) of Annex 3.1 attached hereto will be true and correct as of the date hereof and as
of the Closing and (B) the representations and warranties set forth in clauses (e) through (i) of Annex 3.1 attached hereto will be true
and correct as of the Closing.

 

3.2 Representations
and Warranties of the Equity Investors. Each Equity Investor represents and warrants to the Company that the representations and
warranties set forth in Annex 3.2 attached hereto will be true and correct as of the date hereof and as of the Closing. As of the date
of this Agreement, CKD represents and warrants to the Company that it is in compliance with all applicable rules, regulations, statutes,
decrees, orders, laws and other legal requirements of the Comisión Nacional Bancaria y de Valores in all material respects.

 

    5

     

    

 

4. Additional
Covenants.

 

4.1 Compliance
with Applicable Laws. For so long as any of the Equity Investors holds the Shares, the Company shall be and shall cause each of its
subsidiaries to be, at all times, in compliance with all applicable laws (including with respect to labor practices), except (a) as otherwise
disclosed in the Disclosure Schedule or (b) where the failure to be in compliance could not reasonably be expected to have a material
adverse effect on the operation of the business of the Company and its subsidiaries, taken together on a consolidated basis.

 

4.2 Information
Rights. For so long as any of the Shares are outstanding, the Company shall deliver to each Equity Investor:

 

(a) in
no event later than eighty (80) days after the end of each fiscal year of the Company (commencing with fiscal year 2021), a copy (including,
as applicable, an English or Spanish translation) of the consolidated audited financial statements including balance sheet, statement
of income, stockholders’ equity and cash flow, as of the end of such fiscal year, setting forth in comparative form the figures
for the previous fiscal year and accompanied by an opinion of independent accountants stating that such financial statements present
fairly in all material respects the financial condition of the companies being reported upon and have been prepared in accordance with
GAAP consistently applied (except for changes in application in which such accountants concur);

 

(b) in
no event later than twenty (20) calendar days after the end of each fiscal quarter in each fiscal year of the Company, a copy of the
consolidated and nonconsolidated unaudited balance sheet, statement of income, stockholders’ equity and cash flow of the Company,
correspondingly, as of the end of such fiscal quarter, which financial statements shall be prepared and presented in accordance with
GAAP;

 

(c) in
no event later than twenty (20) calendar days after the end of each calendar month, a copy of the consolidated and nonconsolidated unaudited
financial statements of the Company, correspondingly, as of the end of the previous calendar month; and

 

(d) any
other information reasonably requested by such Equity Investor from time to time to meet its direct or indirect reporting requirements
under applicable rules of the Bolsa Institucional de Valores, S.A. de C.V.

 

4.3 Further
Assurances. The Company, LIVK and each Equity Investor shall execute and deliver such additional documents and take such additional
actions as the Parties reasonably may deem to be practical and necessary in order to consummate the transactions contemplated by this
Agreement.

 

    6

     

    

 

4.4 Non-Occurrence
of the Proposed Transaction. If (i) the Merger Agreement is not entered into by the parties thereto on or prior to March 15, 2021
(other than as a result of LIVK’s failure to negotiate in good faith, including the proposal of any changes in terms from those
set forth in the Business Combination LOI that would be materially adverse to the Company or its shareholders (but except for any such
changes in terms that are a result of feedback from prospective investors with respect to the PIPE Investments (as defined in the Business
Combination LOI))) or (ii) the Merger Agreement is entered into by the parties thereto but subsequently terminated prior to the consummation
of the transactions contemplated thereby (other than as a result of LIVK’s failure to satisfy or perform any of its obligations
under the Merger Agreement), the Company shall, promptly (but, in any event, within three business days) upon LIVK’s request, pay
to LIVK $3,500,000 by wire transfer (in accordance with wire instructions specified by LIVK to the Company) of immediately available
funds in U.S. dollars as reimbursement for LIVK’s transaction-related expenses. The Parties acknowledge that the agreements contained
in this Section 4.4 are an integral part of the transactions contemplated by this Agreement, that, without these agreements, the Parties
would not enter into this Agreement and that any amounts payable pursuant to this Section 4.4 do not constitute a penalty. For the avoidance
of doubt, the first two sentences of this Section 4.4 shall not apply if the Closing does not occur when required under this Agreement
due to the Equity Investors’ failure to fund the Capital Contribution. In addition, in the event that the Closing does not occur
when required under this Agreement due to the Equity Investors’ failure to fund the Capital Contribution, the Company, at its option,
may terminate this Agreement upon notice to the other Parties hereto. Any such termination shall not release any Party of any liability
arising from breaches of this Agreement prior to its termination, and, for purposes of clarity, Sections 3.1, 3.2, 5, 6, 7, 8, 9, 10,
12, 14, 15, 17, 18 and 19 shall survive any such termination of this Agreement.

 

4.5 Disclosure
Schedule. Upon execution of this Agreement, the Company shall deliver to the Equity Investors a disclosure schedule containing exceptions
to the representations and warranties of the Company set forth in Section 3.1(e) through 3.1(i) of this Agreement (the “Disclosure
Schedule”), which exceptions shall be deemed a part of, and shall qualify, any representations and warranties made by the
Company hereunder. During the period from the date of this Agreement through the Closing, the Company may deliver to the Equity Investors
supplements to the Disclosure Schedule containing exceptions to the representations and warranties set forth in Sections 3.1(e) through
3.1(i) of this Agreement, which exceptions shall (x) be deemed a part of, and shall qualify, any representations and warranties made
by the Company hereunder and (y) not qualify the representations and warranties made by the Company hereunder in a manner that would
be material to the Company and its subsidiaries, taken as a whole.

 

5. Confidentiality.
This Agreement shall be treated as confidential and is being entered into by the Parties solely in connection with the agreement of the
Equity Investors to make the Capital Contribution and the Company’s and LIVK’s agreement to amend the Business Combination
LOI as expressly set forth herein. This Agreement may not be used, circulated, quoted or otherwise referred to in any document, except
with the written consent of the Equity Investors and LIVK; provided that the Equity Investors and LIVK agree that the Company
may provide a copy of this Agreement to (i) its lenders and the administrative agent under the Senior Credit Agreement and the lenders
and administrative agent under the Junior Credit Agreement, (ii) the Company’s board of directors and stockholders and (iii) the
Company’s auditors and legal and financial advisors, in each case, so long as such persons are bound by confidentiality obligations
in respect of such disclosure. In addition, any Party may disclose this Agreement in connection with any enforcement of its rights under
this Agreement.

 

    7

     

    

 

6. No
Recourse; Disclaimers.

 

6.1 Notwithstanding
anything that may be expressed or implied in this Agreement or any document or instrument delivered in connection herewith, and notwithstanding
the fact that an Equity Investor may be a partnership, by its acceptance of the benefits of this Agreement, each of the Company, on behalf
of itself and its affiliates, successors, assigns, and representatives (collectively, the “Company Parties”)
and LIVK and the Equity Investors, on behalf of themselves and their respective affiliates, successors, assigns, and representatives
(collectively, the “LIVK Parties”), acknowledges and agrees that (i) no person or entity other than each Equity
Investor and LIVK has any obligations hereunder with respect to the Equity Investors’ and LIVK’s obligations hereunder and
(ii) no person or entity other than the Company has any obligation hereunder with respect to the Company’s obligations hereunder
and that no recourse shall be had hereunder or under any document or instrument delivered in connection herewith, or for any claim based
on, in respect of, or by reason of, such obligations or their creation, against, and no personal liability shall attach to, any Non-Recourse
Party through any borrower or otherwise, whether by or through attempted piercing of the corporate veil, by or through a claim by or
on behalf of any borrower against any Non-Recourse Party, by the enforcement of any assessment or by any legal or equitable proceeding,
by virtue of any statute, regulation or applicable law, or otherwise. Recourse against any Equity Investor and LIVK pursuant to this
Agreement shall be the sole and exclusive remedy of the Company and the other Company Parties and all of their respective affiliates
against any Equity Investor, LIVK and the Non-Recourse Parties in respect of any liabilities or obligations of any Equity Investor or
LIVK arising under, or in connection with, this Agreement. Recourse against the Company pursuant to this Agreement shall be the sole
and exclusive remedy of the Equity Investors, LIVK and the other LIVK Parties and all of their respective affiliates against the Company
and the Non-Recourse Parties in respect of any liabilities or obligations of the Company arising under, or in connection with, this Agreement.

 

6.2 The
Parties hereby agree and acknowledge that, notwithstanding anything to the contrary, the sole and exclusive remedy of the Company against
CKD and/or the LIV LP in the event of any breach of this Agreement by CKD and/or the LIV LP shall be to seek specific performance of
CKD’s and the LIV LP’s obligations to fund the aggregate amount of the Capital Contribution hereunder when due in accordance
with the terms hereof, and the Company agrees and acknowledges that it shall not be entitled to seek any damages against any other Party
hereto. For the avoidance of doubt, the Parties agree that Banco Invex, S.A., Institución de Banca Múltiple, Invex Grupo
Financiero, is acting solely in its capacity as trustee pursuant to the Contrato de Fideicomiso Irrevocable de Emisión
de Certificados Bursátiles Fiduciarios de Desarrollo Número F/2416 identified as “LIV Mexico Growth IV No. F/2416”
and, as such, under no circumstance shall it be held liable with its own assets. Other than their obligations to fund the aggregate amount
of the Capital Contribution hereunder when due in accordance with the terms hereof, CKD and the LIV LP shall not be liable for any claims,
demands, actions, suits or proceedings, whether civil, criminal, administrative or investigative, arising under or in connection with
this Agreement or for any damages in connection with any of the foregoing.

 

7. Expenses.
Each Party shall each bear its own expenses in connection with the negotiation, execution and delivery of this Agreement and the transactions
contemplated hereby; provided that, notwithstanding anything to the contrary, if the Merger Agreement is entered into by the parties
thereto and the transactions contemplated thereby are consummated, New AT (as defined in the Business Combination LOI) shall pay or cause
to be paid all costs and expenses (including fees and expenses of counsel, auditors and financial and other advisors) incurred by the
Company, its subsidiaries, the Equity Investors and LIVK in connection with this Agreement and the transactions herein contemplated.

 

    8

     

    

 

8. Survival.
Unless otherwise set forth in this Agreement, the representations and warranties of the Parties contained in or made pursuant to this
Agreement shall survive the execution and delivery of this Agreement and the Closing until the earlier of (i) the execution of the Merger
Agreement and (ii) (A) with respect to the representations and warranties set forth in clauses (a) through (d) of Annex 3.1 to this Agreement,
the expiration of the applicable statute of limitations or (B) with respect to the representations and warranties set forth in clauses
(e) through (i) of Annex 3.1 to this Agreement, 18 months following the date of this Agreement, and shall in no way be affected by any
investigation or knowledge of the subject matter thereof made by or on behalf of the Parties.

 

9. Trust
Account Waiver. The Company and the Equity Investors acknowledge that LIVK is a blank check company formed for the purpose of entering
into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination
with one or more businesses or entities. The Company and the Equity Investors further acknowledge that, as described in LIVK’s
prospectus relating to its initial public offering dated December 10, 2019 (the “Prospectus”) available at
www.sec.gov, substantially all of LIVK’s assets consist of the cash proceeds of LIVK’s initial public offering and private
placement of its securities, and substantially all of those proceeds have been deposited in a trust account (the “Trust Account”)
for the benefit of LIVK, its public shareholders and the underwriter of LIVK’s initial public offering. Except with respect to
interest earned on the funds held in the Trust Account that may be released to LIVK to pay its tax obligations, if any, the cash in the
Trust Account may be disbursed only for the purposes set forth in the Prospectus. For and in consideration of LIVK entering into this
Agreement, the receipt and sufficiency of which are hereby acknowledged, each of the Company and each Equity Investor hereby irrevocably
waives any and all right, title and interest, or any claim of any kind it has or may have in the future, in or to any monies held in
the Trust Account, and agrees not to seek recourse against the Trust Account as a result of, or arising out of, this Agreement.

 

    9

     

    

 

10. Notices.
Unless otherwise provided in this Agreement, all notices or demands relating to this Agreement shall be in writing and shall be personally
delivered or sent by registered or certified mail (postage prepaid, return receipt requested), overnight courier, electronic mail (at
such email addresses as a Party may designate in accordance herewith), or telefacsimile. In the case of notices or demands to the Company,
they shall be sent to: AgileThought, Inc., 222 Urban Towers, Suite 1650 E, Irving, TX 75039, Attention: Manuel Senderos, manuel.senderos@agilethought.com,
Jorge Pliego, jorge.pliego@agilethought.com and Laurie Harrison, laurie.harrison@agilethought.com. In the case of notices or demands
to CKD, they shall be sent to Boulevard Manuel Ávila Camacho 40-9, Lomas de Chapultepec I Sección, Alcaldía Miguel
Hidalgo, C.P. 11000, Ciudad de México, México, Attention: División Fiduciaria, arossi@livcapital.mx, hzesati@livcapital.mx,
mdavila@livcapital.mx, with a copy to Administradora LIV Capital, S.A.P.I. de C.V., Pedregal #24-601, Molino del Rey, Alcaldía
Miguel Hidalgo, C.P. 11040, Ciudad de México, México, Attention: Mariano Romero, mromero@livcapital.mx. In the case of
notices or demands to the LIV LP, they shall be sent to 330 East 79th Street, Suite 1D, New York, NY 10075, United States of America,
Attention: Alex Rossi, Humberto Zesati y Miguel Ángel Dávila, arossi@livcapital.mx, hzesati@livcapital.mx, mdavila@livcapital.mx,
with a copy to Pedregal #24-601, Molino del Rey, Alcaldía Miguel Hidalgo, C.P. 11040, Ciudad de México, México,
Attention: Mariana Romero, arossi@livcapital.mx, hzesati@livcapital.mx, mdavila@livcapital.mx and mromero@livcapital.mx. In the case
of notice or demands to LIVK, they shall be sent to Pedregal #24-601, Molino del Rey, Alcaldía Miguel Hidalgo, C.P. 11040, Ciudad
de México, México, Attention: Mariana Romero, arossi@livcapital.mx, hzesati@livcapital.mx, mdavila@livcapital.mx, and mromero@livcapital.mx.
Copies of all notices to CKD, the LIV LP or LIVK shall also be sent to Davis Polk & Wardwell LLP, 450 Lexington Avenue, New York,
NY 10017, Attention: Lee Hochbaum and Derek Dostal, lee.hochbaum@davispolk.com, derek.dostal@davispolk.com. Any Party hereto may change
the address or other contact information at which they are to receive notices hereunder, by notice in writing in the foregoing manner
given to the other Party. All notices or demands sent in accordance with this Section 7, shall be deemed received on the earlier of the
date of actual receipt or three business days after the deposit thereof in the mail; provided, that (a) notices sent by overnight
courier service shall be deemed to have been given when received, (b) notices by facsimile shall be deemed to have been given when sent
(except that, if not given during normal business hours for the recipient, shall be deemed to have been given at the opening of business
on the next business day for the recipient) and (c) notices by electronic mail shall be deemed received upon the sender’s receipt
of an acknowledgment from the intended recipient (such as by the “return receipt requested” function, as available, return
email or other written acknowledgment).

 

11. Amendment.
This Agreement may not be amended or, except as otherwise set forth herein, terminated or any provisions waived without the prior written
consent of each of the Parties.

 

12. No
Other Beneficiaries; Remedies. This Agreement is solely for the benefit of the Parties and is not intended to, nor does it, confer
any benefits on, or create any rights or remedies in favor of, any person or entity other than the Parties. In the event of any Party’s
breach of its obligations under the terms of this Agreement, the other Parties shall be entitled to specific performance or other injunctive
or equitable relief to compel the breaching Party’s performance (without having to secure or post any bond), in addition to any
and all other rights and remedies at law or in equity, and all such rights and remedies shall be cumulative.

 

13. Counterparts,
Etc. This Agreement may be executed in any number of counterparts, each of which will be deemed an original, but all of which together
will constitute but one and the same instrument. This Agreement will become effective when duly executed and delivered by each Party
hereto.

 

14. Construction
of Agreement. This Agreement has been reviewed by each of the Parties and their counsel and shall be construed and interpreted according
to the ordinary meaning of the words used so as to fairly accomplish the purposes and intentions of the Parties.

 

    10

     

    

 

15. Severability
of Provisions. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction,
be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof or affecting
the validity or enforceability of such provision in any other jurisdiction.

 

16. Assignment.
Each Equity Investor reserves the right, prior to or after execution hereof, to assign any portion of the Capital Contribution under
Section 2 hereunder to one or more affiliates, financing sources or other investors and upon the actual timely funding of such assigned
portion of the Capital Contribution, each Equity Investor shall have no further obligation to the Company (or any other person or entity)
with respect thereto (it being understood that until, and to the extent, that such assigned portion of the Capital Contribution is actually
timely funded in the manner described in Section 2, no such assignment shall relieve the Equity Investors of their obligation to invest
the full amount of the Capital Contribution). The rights of the Company under this Agreement may not be assigned in any manner without
the prior written consent of the Equity Investors and LIVK and any attempted assignment in violation of this provision by the Company
shall render the Capital Contribution of no further force or effect. Except as provided in the first sentence of this Section 16, the
rights of the Equity Investors and/or LIVK under this Agreement may not be assigned in any manner without the prior written consent of
the Company, and any attempted assignment in violation of this provision by any Equity Investor or LIVK shall be null and void and of
no further force or effect.

 

17. Governing
Law; Jurisdiction; Waiver of Jury Trial.

 

17.1 Governing
Law. All matters relating to or arising out of this Agreement or the transactions contemplated hereby (whether sounding in contract,
tort or otherwise) will be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to any
choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the
application of the laws of any jurisdiction other than the State of Delaware.

 

17.2 Jurisdiction.
Each Party hereto consents to the exclusive jurisdiction of any state or federal court located within the county of New Castle in
the State of Delaware and irrevocably agrees that all actions or proceedings relating to this Agreement or the transactions contemplated
hereby may be litigated only in such courts. Each Party hereto accepts for itself and in connection with its respective properties, generally
and unconditionally, the jurisdiction of such courts and waives any defense of forum non conveniens, and irrevocably agrees to
be bound by any judgment rendered thereby in connection with this Agreement or the transactions contemplated hereby. Each Party hereto
irrevocably consents to the service of process out of any such courts in any such action or proceeding by the mailing of copies thereof
by registered or certified mail, postage prepaid, to such Party at the address specified in this Agreement, with such service to become
effective 15 calendar days after such mailing. Nothing herein shall in any way be deemed to limit the ability or either Party hereto
to serve any such legal process, summons, notices or documents in any other manner permitted by applicable law. Notwithstanding the foregoing,
a Party hereto may commence an action in a court other than the above-named courts for the purpose of enforcing an order issued by one
of the above-named courts.

 

    11

     

    

 

17.3 Waiver
of Jury Trial. EACH PARTY HEREBY IRREVOCABLY WAIVES AND COVENANTS THAT IT WILL NOT ASSERT, TO THE FULLEST EXTENT PERMITTED BY LAW,
ALL RIGHT TO TRIAL BY JURY IN ANY ACTION (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT,
ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY OR THE ACTIONS OF ANY PARTY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT
HEREOF, WHETHER NOW EXISTING OR HEREAFTER ARISING. THE PARTIES AGREE THAT ANY OF THEM MAY FILE A COPY OF THIS PARAGRAPH WITH ANY COURT
AS WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY AND BARGAINED-FOR AGREEMENT AMONG THE PARTIES IRREVOCABLY TO WAIVE THEIR RESPECTIVE RIGHTS
TO TRIAL BY JURY IN ANY ACTION WHATSOEVER BETWEEN OR AMONG THEM RELATING TO THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREBY
OR THEREBY AND THAT SUCH ACTIONS WILL INSTEAD BE TRIED IN A COURT OF COMPETENT JURISDICTION BY A JUDGE SITTING WITHOUT A JURY.

 

18. Interpretation.
Unless the context of this Agreement clearly requires otherwise, references to the plural include the singular and to the singular include
the plural, the part includes the whole, the terms “including” and “include” are not limiting, and the term “or”
has, except where otherwise indicated, the inclusive meaning represented by the phrase “and/or.” The words “hereof,”
“herein,” “hereby,” “hereunder,” and similar terms in this Agreement refer to this Agreement as a
whole and not to any particular provision of this Agreement. Article, clause, paragraph, section, subsection, exhibit, and schedule references
are to this Agreement unless otherwise specified.

 

19. Miscellaneous.
Each Party acknowledges and agrees that (a) this Agreement is not intended to, and does not, create any agency, partnership, fiduciary
or joint venture relationship between or among any of the Parties hereto and neither this Agreement nor any other document or agreement
entered into by any Party hereto relating to the subject matter hereof shall be construed to suggest otherwise and (b) the obligations
of the Equity Investors under this Agreement are solely contractual and not fiduciary in nature. This Agreement and any signed agreement
or instrument entered into in connection with this Agreement, and any amendments or waivers hereto or thereto, to the extent signed and
delivered by means of a facsimile machine or by e-mail delivery of a “.pdf” format data file, shall be treated in all manner
and respects as an original agreement or instrument and shall be considered to have the same binding legal effect as if it were the original
signed version thereof delivered in person. No Party hereto or to any such agreement or instrument shall raise the use of a facsimile
machine or e-mail delivery of a “.pdf” format data file to deliver a signature to this Agreement or any amendment hereto
or the fact that any signature or agreement or instrument was transmitted or communicated through the use of a facsimile machine or e-mail
delivery of a “.pdf” format data file as a defense to the formation of a contract and each Party hereto forever waives any
such defense.

 

[SIGNATURE
PAGES FOLLOW]

 

    12

     

    

 

IN
WITNESS WHEREOF, the undersigned have executed this Equity Contribution Agreement as of the date first written above.

 

	COMPANY:	AgileThought, Inc.
	 	 
	 	By:	/s/ Manuel Senderos Fernandez
	 	Name:	Manuel Senderos Fernandez
	 	Title:	Chief Executive Officer
	 	 	 
	EQUITY INVESTORS:	BANCO INVEX, S.A., INSTITUCIÓN DE BANCA MÚLTIPLE, INVEX GRUPO FINANCIERO, ACTING SOLELY IN ITS CAPACITY AS TRUSTEE PURSUANT TO THE CONTRATO DE FIDEICOMISO IRREVOCABLE DE EMISIÓN DE CERTIFICADOS BURSÁTILES FIDUCIARIOS DE DESARROLLO NÚMERO F/2416 IDENTIFIED AS “LIV MEXICO GROWTH IV NO. F/2416”
	 	 	 
	 	By: Administradora LIV Capital, S.A.P.I. de C.V.
	 	 
	 	By:	/s/ Alexander Roger Rossi
	 	Name:	Alexander Roger Rossi
	 	Title:	Attorney-in-fact
	 	 	 
	 	LIV MEXICO GROWTH FUND IV, L.P.
	 	 
	 	By:	/s/ Alexander Roger Rossi
	 	Name:	Alexander Roger Rossi
	 	Title:	Attorney-in-fact
	 	 	 
	 	LIVK:	LIV Capital Acquisition Corp.
	 	 	 
	 	By:	/s/ Alexander Roger Rossi
	 	Name:	Alexander Roger Rossi
	 	Title:	Chief Executive Officer and Chairman

 

    13Exhibit 10.17

 

AMENDED AND RESTATED EMPLOYMENT AGREEMENT

 

This Amended
and Restated Employment Agreement (the “Agreement”) is entered into effective as of August 4, 2020
(the “Effective Date”), by and between Manuel Senderos Fernández (“Executive”)
and AgileThought, LLC (the “Company”).

 

Executive has been employed
by the Company as its Chairman and Chief Executive Officer;

 

The Company desires to continue
to employ Executive and, in connection therewith, to compensate Executive for Executive’s personal services to the Company; and

 

Executive wishes to continue
to be employed by the Company and provide personal services to the Company in return for certain compensation.

 

Accordingly, in consideration
of the mutual promises and covenants contained herein, the parties agree to the following:

 

		1.	Employment by the
Company.

 

1.1 At-Will
Employment. Executive shall continue to be employed by the Company on an “at-will” basis, meaning either the Company
or Executive may terminate Executive’s employment at any time, with or without Cause (as defined in Section 6.2(g) below), Good
Reason (as defined in Section 6.2(f) below), or advance notice. Any contrary representations that may have been made to Executive shall
be superseded by this Agreement. This Agreement shall constitute the full and complete agreement between Executive and the Company on
the “at-will” nature of Executive’s employment with the Company, which may be changed only in an express written agreement
signed by Executive and a duly authorized officer of the Company. Executive’s rights to any salary or cash bonus following a termination
shall be only as set forth in Section 6 or under any applicable benefit or equity plan.

 

1.2 Position.
Subject to the terms set forth herein, the Company agrees to continue to employ Executive and Executive hereby accepts such continued
employment. In addition, Executive shall continue to serve as Chairman and Chief Executive Officer. During the term of Executive’s
employment with the Company, and excluding periods of vacation and sick leave to which Executive is entitled, Executive shall devote all
business time and attention to the affairs of the Company necessary to discharge the responsibilities assigned hereunder, and shall use
commercially reasonable efforts to perform faithfully and efficiently such responsibilities.

 

1.3 Duties.
Executive will report to the Company’s Board of Directors (the “Board”) and will render such business
and professional services in the performance of Executive’s duties, consistent with Executive’s position as Chairman and Chief
Executive Officer, as shall reasonably be assigned to him by the Board. Executive shall perform Executive’s duties under this Agreement
from such location(s) as may be assigned by the Company and shall make such business trips to such places as may be reasonably necessary
or advisable for the efficient operations of the Company.

 

1.4 Company
Policies and Benefits. The employment relationship between the parties shall continue to be subject to the Company’s written
personnel policies and procedures as they may be adopted, revised, or deleted from time to time in the Company’s sole discretion.
Executive shall be expected to continue to comply with all applicable laws, regulations, rules, directives and other legal requirements
of federal, state and other governmental and regulatory bodies having jurisdiction over the Company and of the professional bodies of
which the Company is a member. During Executive’s employment with the Company, Executive continues to be required to maintain in
good standing any licenses and certifications necessary for the performance of Executive’s duties for the Company.  Executive
will continue to be eligible to participate on the same basis as similarly-situated employees in the Company’s benefit plans in
effect from time to time during Executive’s employment. Subject to the preceding sentence, the Company reserves the right to change,
alter, or terminate any benefit plan in its sole discretion. All matters of eligibility for coverage or benefits under any benefit plan
shall be determined in accordance with the provisions of such plan. Notwithstanding the foregoing, in the event that the terms of this
Agreement differ from or are in conflict with the Company’s general employment policies or practices, this Agreement shall control.
The parties acknowledge that as of the Effective Date of this Agreement, the Company’s current vacation policy provides that any
accrued but unused vacation will not be paid out upon termination of Executive’s employment unless otherwise required by applicable
law.

 

     

     

    

 

		2.	Compensation.

 

2.1 Salary.
Executive shall receive an annualized base salary of $450,000, subject to further review and adjustment from time to time by the Company
in its sole discretion, payable subject to standard federal and state payroll withholding requirements in accordance with the Company’s
standard payroll practices (the “Base Salary”).

 

2.2 Bonus.

 

(a) During
Employment. Executive shall be eligible to earn a quarterly performance bonus with respect to each calendar quarter (each, a “Quarterly
Bonus”) based upon such Quarterly Bonus target amounts and performance objectives as may be set forth annually in a schedule
(each, a “Quarterly Bonus Schedule”) to be pre-determined by the Company and provided to Executive. Attached
hereto as Exhibit A is the applicable Quarterly Bonus Schedule for calendar year 2020. The Quarterly Bonuses will be awarded
based upon the assessment by Board of the Company’s attainment of the targeted goals set forth by the Company in the applicable
Quarterly Bonus Schedule, as determined by the Board in its reasonable good faith discretion.  The Quarterly Bonuses, if any, will
be subject to applicable payroll deductions and withholdings.  Following the close of each quarter of each calendar year, the Board
(or any authorized committee thereof) will determine whether Executive has earned such quarter’s applicable Quarterly Bonus and
the amount of any Quarterly Bonus, on the bases described above and as set forth on the applicable Bonus Schedule. No amount of any Quarterly
Bonus is guaranteed at any time, and, except as otherwise stated in Sections 6.2(a)(iii) or 6.3(a)(iii), Executive must be an employee
in good standing through the date a respective Quarterly Bonus is paid to be eligible to receive such Quarterly Bonus.  Subject to
Sections 6.2 and 6.3 related to payments upon certain terminations of employment, any Quarterly Bonus, if earned, will be paid at the
same time quarterly bonuses are generally paid to other similarly-situated employees of the Company.  Executive’s eligibility
for a Quarterly Bonus is subject to change in the discretion of the Board (or any authorized committee thereof).

 

(b) Upon
Termination. Subject to the provisions of Section 6, in the event Executive leaves the employ of the Company for any reason prior
to the date a Quarterly Bonus is paid, Executive is not eligible to earn such Quarterly Bonus, prorated or otherwise.

 

2.3 Equity.
Subject to approval by the Board of Directors (the “Parent Board”) of AgileThought, Inc. (“Parent”),
Parent shall, as soon as practicable following the Effective Date, grant Executive a restricted stock unit award covering shares of Parent’s
Class A common stock (the “RSU”) with a grant date fair value of $2,500,000, pursuant to Parent’s 2020
Equity Incentive Plan (the “Plan”).  The number of shares of Parent’s Class A common stock subject
to the RSU shall be determined based on the fair market value of Parent’s Class A common stock on the grant date, as determined
in good faith by the Parent Board, assuming that Parent’s equity value (net of debt) as of the grant date is $700,000,000. The RSU
shall be granted pursuant to the Plan and shall be subject to the terms and conditions of the Plan and a restricted stock unit award agreement
providing for a valuation modifier (the “RSU Agreement”) thereunder.  The RSU shall vest upon the satisfaction
of both time-based and liquidity event requirements. The time-based requirement shall be satisfied as follows: one-third (1/3rd) of
the shares underlying the RSU shall vest on each of the first three anniversaries of the grant date, subject to Executive’s Continuous
Service (as defined in the Plan) through each applicable vesting date. The liquidity event requirement shall be satisfied on the first
to occur of a Change in Control or the first business day following the expiration of the lock-up period specified in the RSU Agreement,
provided that Executive is in Continuous Service immediately prior to such event. Notwithstanding the foregoing, the RSU shall be subject
to the potential vesting acceleration of Section 6.3(a)(iv). Executive agrees to be bound by the terms and conditions of any shareholders
agreement by and among Parent and its stockholders.

 

2.4 Future
Equity Awards. Executive remains eligible to be considered for future equity awards as may be determined by the Parent Board or
a committee of the Parent Board in its discretion in accordance with the terms of any applicable equity plan or arrangement that may be
in effect from time to time.

 

    2

     

    

 

2.5 Expense
Reimbursement. The Company will issue to Executive a Company credit card for business expenses and shall continue to reimburse
Executive for reasonable out-of-pocket business expenses in accordance with the Company’s standard expense reimbursement policy;
provided that such reimbursements, to the extent taxable under applicable law, will be subject to applicable deductions and withholdings.
For the avoidance of doubt, to the extent that any reimbursements payable to Executive are subject to the provisions of Section 409A of
the Internal Revenue Code of 1986, as amended (the “Code”): (a) any such reimbursements will be paid no later
than December 31 of the year following the year in which the expense was incurred, (b) the amount of expenses reimbursed in one year will
not affect the amount eligible for reimbursement in any subsequent year, and (c) the right to reimbursement under this Agreement will
not be subject to liquidation or exchange for another benefit.

 

3. Confidential
Information, Inventions, Non-Solicitation and Non-Competition Obligations. In connection with Executive’s continued
employment with the Company, Executive will continue to receive and continue to have access to the Company’s confidential information
and trade secrets. Accordingly, and in consideration of the benefits that Executive is eligible to receive under this Agreement, Executive
agrees to sign the Company’s Employee Confidential Information, Inventions, Non-Solicitation and Non-Competition Agreement (the
“Confidential Information Agreement”), attached as Exhibit B, which contains restrictive covenants
and prohibits unauthorized use or disclosure of the Company’s confidential information and trade secrets, among other obligations.
The Confidential Information Agreement contains provisions that are intended by the parties to survive and do survive termination or expiration
of this Agreement.

  

4. Outside
Activities. Except with the prior written consent of the Board, Executive will not, while employed by the Company, undertake
or engage in any other employment, occupation, or business enterprise that would interfere with Executive’s responsibilities and
the performance of Executive’s duties hereunder except for (i) reasonable time devoted to volunteer services for or on behalf of
such religious, educational, non-profit, and/or other charitable organization as Executive may wish to serve, (ii) reasonable time devoted
to activities in the non-profit and business communities consistent with Executive’s position with the Company, (iii) reasonable
time serving as trustee, director, or advisor to any family companies or trusts, or (iv) with prior written notice to the Board, reasonable
time devoted to service as a member of the board of directors (or its equivalent in the case of a non-corporate entity) of a non-competing
business; so long as the activities set forth in clauses (i), (ii), (iii), and (iv) do not interfere, individually or in the aggregate,
with the performance of Executive’s duties for the Company, are not competitive with the business of the Company, will not otherwise
result in Executive’s breach of the Confidential Information Agreement, or create a business or fiduciary conflict. This restriction
shall not, however, preclude Executive from (x) owning less than one percent (1%) of the total outstanding shares of a publicly traded
company, (y) managing Executive’s passive personal investments, or (z) employment or service in any capacity with Affiliates of
the Company. As used in this Agreement, “Affiliates” means, at the time of determination, any “parent”
or “subsidiary” of the Company as such terms are defined in Rule 405 of the Securities Act of 1933, as amended. The Board
will have the authority to determine the time or times at which “parent” or “subsidiary” status is determined
within the foregoing definition.

 

5. No
Conflict with Existing Obligations. Executive represents that Executive’s performance of all the terms of this Agreement
and continued service as an employee of the Company do not and will not breach any agreement or obligation of any kind made prior to Executive’s
employment by the Company, including agreements or obligations Executive may have with prior employers or entities for which Executive
has provided services. Executive has not entered into, and Executive agrees that Executive will not enter into, any agreement or obligation,
either written or oral, in conflict herewith or with Executive’s duties to the Company.

 

6. Termination
Of Employment. The parties acknowledge that Executive’s employment relationship with the Company continues to be
at-will. Either Executive or the Company may terminate the employment relationship at any time, with or without Cause (as defined below)
or advance notice. The provisions in this Section govern the amount of compensation, if any, to be provided to Executive upon termination
of employment and do not alter this at-will status.

 

6.1 Termination
by Virtue of Death or Disability of Executive.

 

(a) In
the event of Executive’s death while employed pursuant to this Agreement, all obligations of the parties hereunder and Executive’s
employment shall terminate immediately, and the Company shall, pursuant to the Company’s standard payroll policies and applicable
law, pay to Executive’s legal representatives the Accrued Obligations (as defined in Section 6.2(e) below) due to Executive.

 

    3

     

    

 

(b) Subject
to applicable state and federal law, the Company shall at all times have the right, upon written notice to Executive, to terminate this
Agreement based on Executive’s Disability (as defined below). Termination by the Company of Executive’s employment based on
“Disability” shall mean termination because Executive is unable due to a physical or mental condition to perform
the essential functions of Executive’s position with or without reasonable accommodation for six (6) months in the aggregate during
any twelve (12) month period or based on the written certification by two licensed physicians of the likely continuation of such condition
for such period. This definition shall be interpreted and applied consistent with the Americans with Disabilities Act, the Family and
Medical Leave Act, and other applicable law. In the event Executive’s employment is terminated based on Executive’s Disability,
Executive will be entitled to the Accrued Obligations due to Executive.

 

6.2 Termination
by the Company or Resignation by Executive.

 

(a) The
Company shall have the right to terminate Executive’s employment pursuant to this Section 6.2 at any time (subject to any applicable
cure period stated in Section 6.2(f)) with or without Cause or advance notice, by giving notice as described in Section 7.1 of this Agreement.
Likewise, Executive can resign from employment with or without Good Reason, by giving notice as described in Section 7.1 of this Agreement.
Executive hereby agrees to comply with the additional notice requirements set forth in Section 6.2(f) below for any resignation for Good
Reason. If Executive is terminated by the Company (with or without Cause) or resigns from employment with the Company (with or without
Good Reason), then Executive shall be entitled to the Accrued Obligations (as defined below). In addition, if Executive is terminated
without Cause or resigns for Good Reason, and provided that such termination constitutes a “separation from service” (as defined
under Treasury Regulation Section 1.409A-1(h), without regard to any alternative definition thereunder, a “Separation from
Service”), and further provided that Executive executes and allows to become effective a separation agreement that includes,
among other terms, a general release of claims in favor of the Company and its Affiliates and representatives, in the form presented by
the Company (the “Separation Agreement”), and subject to Section 6.2(b) (the date that the general release of
claims in the Separation Agreement becomes effective and may no longer be revoked by Executive is referred to as the “Release
Date”), then Executive shall be eligible to receive the following severance benefits (collectively the “Non-CIC
Severance Benefits”):

 

(i) An
amount equal to twelve (12) months of Executive’s then current Base Salary, less standard payroll deductions and withholdings,
paid in installments on the Company’s regular payroll dates;

 

(ii) Provided
Executive or Executive’s covered dependents, as the case may be, timely elect continued coverage under COBRA under the Company’s
group health plans following such termination, the portion of the COBRA premiums which is equal to the cost of the coverage that the Company
was paying as of the date of termination, to continue Executive’s (and Executive’s covered dependents’, as applicable)
health insurance coverage in effect on the termination date until the earliest of: (1) twelve (12) months following the termination
date; (2) the date when Executive becomes eligible for substantially equivalent health insurance coverage in connection with new employment
or self-employment; or (3) the date Executive ceases to be eligible for COBRA continuation coverage for any reason, including plan termination
(such period from the termination date through the earlier of (1)-(3), (the “COBRA Payment Period”)). Notwithstanding
the foregoing, if at any time the Company determines that its payment of COBRA premiums on Executive’s behalf would result in a
violation of applicable law (including, but not limited to, the 2010 Patient Protection and Affordable Care Act, as amended by the 2010
Health Care and Education Reconciliation Act), then in lieu of paying COBRA premiums pursuant to this Section, the Company shall pay Executive
on the last day of each remaining month of the COBRA Payment Period, a fully taxable cash payment equal to the COBRA premium for such
month, subject to applicable tax withholding, for the remainder of the COBRA Payment Period. Nothing in this Agreement shall deprive Executive
of Executive’s rights under COBRA or ERISA for benefits under plans and policies arising under Executive’s employment by the
Company; and

 

(iii) Executive
shall be eligible to receive a lump sum cash payment in an amount equal to the sum of the Quarterly Bonus amounts for each quarter in
the calendar year in which Executive’s termination occurs, paid at target level (as set forth in the applicable Quarterly Bonus
Schedule provided to Executive by the Company for such year), with the amount of the Quarterly Bonus applicable to the calendar quarter
in which Executive ceases employment prorated to reflect the portion of the calendar quarter in which Executive remained employed by the
Company; provided, however, that such lump sum payment shall be reduced by any Quarterly Bonus amounts already earned and paid to Executive
for the calendar year in which Executive’s termination occurs. This lump sum, subject to standard payroll deductions and withholdings,
shall be paid on the next date on which Quarterly Bonuses are scheduled to be paid (subject to Section 6.2(c)), which in no event will
be later than March 15 of the calendar year following the year in which the termination date occurs.

 

    4

     

    

 

(b) Executive
shall not receive the Non-CIC Severance Benefits pursuant to Section 6.2(a) unless Executive executes the Separation Agreement within
the consideration period specified therein, which shall in no event be more than forty-five (45) days, and until the Separation Agreement
becomes effective and can no longer be revoked by Executive under its terms. Executive’s ability to receive benefits pursuant to
Section 6.2(a) is further conditioned upon Executive: (i) returning all Company property; (ii) complying with Executive’s post-termination
obligations under this Agreement and the Confidential Information Agreement; (iii) complying with the Separation Agreement, including
without limitation any non-disparagement and confidentiality provisions contained therein; and (iv) resignation from any other positions
Executive holds with the Company, effective no later than Executive’s date of termination (or such other date as requested by the
Board).

 

(c) The
Company will not make any payments to Executive with respect to any of the benefits pursuant to Section 6.2(a) prior to the
60th day following Executive’s date of termination. On the first payroll date after the 60th day following Executive’s date
of termination, and provided that Executive has delivered an effective Separation Agreement, the Company will (i) make the first payment
to Executive under Section 6.2(a)(i) and, in a lump sum, an amount equal to the aggregate amount of payments that the Company would
have paid Executive through such date had the payments commenced on Executive’s date of termination through such 60th day, with
the balance of the payments paid thereafter on the schedule described above, and (ii) make the lump sum payment specified in Section 6.2(a)(iii)
that has not yet been made due to this Section 6.2(c), in the cases of (i) and (ii) subject to any delay in payment required by Section
6.6.

 

(d) Subject
to any delay in payment required by Section 6.6

 

(e) For
purposes of this Agreement, “Accrued Obligations” are (i) Executive’s accrued but unpaid salary through
the date of termination and, if required by applicable law and the Company’s applicable policy as of the time of termination, any
accrued but unused vacation through the date of termination (both of which, for purpose of clarity, shall be paid in cash), (ii) any unreimbursed
business expenses incurred by Executive payable in accordance with the Company’s standard expense reimbursement policies, and (iii)
benefits owed to Executive under any qualified retirement plan or health and welfare benefit plan in which Executive was a participant
in accordance with applicable law and the provisions of such plan.

 

(f) For
purposes of this Agreement, “Good Reason” means any of the following actions taken by the Company without Executive’s
express prior written consent: (i) a material reduction by the Company of Executive’s Base Salary (other than in a broad based reduction
similarly affecting all other members of the Company’s executive management); (ii) a material breach by the Company of this
Agreement or any other material written agreement between Executive and the Company concerning the terms and conditions of Executive’s
employment; (iii) the relocation of Executive’s principal place of employment, without Executive’s consent, to a
place that increases Executive’s one-way commute by more than fifty (50) miles as compared to Executive’s then-current principal
place of employment immediately prior to such relocation; or (iv) a material reduction in Executive’s duties, authority,
or responsibilities for the Company relative to Executive’s duties, authority, or responsibilities in effect immediately prior to
such reduction; provided, however, that, any such termination by Executive shall only be deemed for Good Reason pursuant to this definition
if: (1) Executive gives the Company written notice of Executive’s intent to terminate for Good Reason within thirty (30) days following
Executive’s learning of the occurrence of the condition(s) that Executive believes constitute(s) Good Reason, which notice shall
describe such condition(s); (2) the Company fails to remedy such condition(s) within thirty (30) days following receipt of the written
notice (the “Cure Period”); and (3) Executive voluntarily terminates Executive’s employment within
thirty (30) days following the end of the Cure Period. For the avoidance of doubt, any change in Executive’s title or the entity
structure of the Company, in each case, without a corresponding material reduction in Executive’s duties, authority, or responsibilities,
in accordance with clause (iv) above, shall not constitute Good Reason.

 

(g) For
purposes of this Agreement, “Cause” for termination shall mean that the Company has determined in its sole discretion
that Executive has engaged in any of the following: (i) a material breach of any covenant or condition under this Agreement or any other
agreement between the parties; (ii) any act constituting dishonesty, fraud, immoral or disreputable conduct which is reasonably likely
to cause harm (including reputational harm) to the Company; (iii) any conduct which constitutes a felony under applicable law; (iv)
material violation of any Company policy, after the expiration of ten (10) days without cure after written notice of such violation to
the extent such violation is curable; (v) refusal to follow or implement a clear, lawful and reasonable directive of Company after the
expiration of ten (10) days without cure after written notice of such failure to the extent such failure is curable; (vi) gross negligence
or incompetence in the performance of Executive’s duties after the expiration of ten (10) days without cure after written notice
of such failure; or (vii) breach of fiduciary duty.

 

(h) The
benefits provided to Executive pursuant to this Section 6.2 are in lieu of, and not in addition to, any benefits to which Executive may
otherwise be entitled under any Company severance plan, policy, or program.

 

(i) Any
damages caused by the termination of Executive’s employment without Cause or for Good Reason would be difficult to ascertain; therefore,
the Non-CIC Severance Benefits for which Executive is eligible pursuant to Section 6.2(a) above in exchange for the Separation Agreement
is agreed to by the parties as liquidated damages, to serve as full compensation, and not a penalty.

 

(j) If
the Company terminates Executive’s employment for Cause, or Executive resigns from employment with the Company without Good Reason,
regardless of whether or not such termination is in connection with a Change in Control (as defined in the Plan), then Executive shall
be entitled to the Accrued Obligations, but Executive will not receive the Non-CIC Severance Benefits, the CIC Severance Benefits, or
any other severance compensation or benefit.

 

    5

     

    

 

6.3 Resignation
by Executive for Good Reason or Termination by the Company without Cause (in connection with a Change in Control).

 

(a) In
the event that the Company terminates Executive’s employment without Cause or Executive resigns for Good Reason within twelve (12)
months following the effective date of a Change in Control (“Change in Control Termination Date”), then Executive
shall be entitled to the Accrued Obligations and, subject to Executive’s compliance with Section 6.2(b) above, Executive shall be
eligible to receive the following severance benefits (collectively the “CIC Severance Benefits”), subject to the terms
and conditions set forth in Section 6.3(b):

 

(i) An
amount equal to twelve (12) months of Executive’s then current Base Salary, less standard payroll deductions and withholdings,
paid in installments on the Company’s regular payroll dates;

 

(ii) Provided
Executive or Executive’s covered dependents, as the case may be, timely elects continued coverage under COBRA under the Company’s
group health plans following such termination, the portion of the COBRA premiums which is equal to the cost of the coverage that the Company
was paying as of the date of termination, to continue Executive’s (and Executive’s covered dependents, as applicable) health
insurance coverage in effect on the termination date until the earliest of: (1) twelve (12) months following the termination date;
(2) the date when Executive becomes eligible for substantially equivalent health insurance coverage in connection with new employment
or self-employment; or (3) the date Executive ceases to be eligible for COBRA continuation coverage for any reason, including plan termination
(such period from the termination date through the earlier of (1)-(3), (the “CIC COBRA Payment Period”). Notwithstanding
the foregoing, if at any time the Company determines that its payment of COBRA premiums on Executive’s behalf would result in a
violation of applicable law (including, but not limited to, the 2010 Patient Protection and Affordable Care Act, as amended by the 2010
Health Care and Education Reconciliation Act), then in lieu of paying COBRA premiums pursuant to this Section, the Company shall pay Executive
on the last day of each remaining month of the CIC COBRA Payment Period, a fully taxable cash payment equal to the COBRA premium for such
month, subject to applicable tax withholding, for the remainder of the CIC COBRA Payment Period. Nothing in this Agreement shall deprive
Executive of Executive’s rights under COBRA or ERISA for benefits under plans and policies arising under Executive’s employment
by the Company;

 

(iii) Executive
shall be eligible to receive a lump sum cash payment in an amount equal to the sum of the Quarterly Bonus amounts for each quarter in
the calendar year in which Executive’s termination occurs, paid at target level, as set forth in the applicable Quarterly Bonus
Schedule provided to Executive by the Company for such year. This lump sum, subject to standard payroll deductions and withholdings, shall
be paid on the next date on which Quarterly Bonuses are scheduled to be paid (subject to Section 6.3(b)), which in no event will be later
than March 15 of the calendar year following the year in which the termination date occurs; and

 

(iv) Effective
as of Executive’s Change in Control Termination Date, the vesting and exercisability of all outstanding equity awards held by Executive
immediately prior to the Change in Control Termination Date, including the RSU, shall be accelerated in full. Such awards shall remain
outstanding following Executive’s Change in Control Termination Date if and to the extent necessary to give effect to this Section 6.3(a)(iv)
subject to earlier termination under the terms of the equity incentive plan under which such awards were granted and the original maximum
term of the award (without regard to Executive’s termination).

 

(b) The
Company will not make any payments to Executive with respect to any of the benefits pursuant to Section 6.3(a) prior to the
60th day following Executive’s date of termination. On the first payroll date after the 60th day following Executive’s date
of termination, and provided that Executive has delivered an effective Separation Agreement, the Company will (i) make the first
payment to Executive under Section 6.3(a)(i) and, in a lump sum, an amount equal to the aggregate amount of payments that the Company
would have paid Executive through such date had the payments commenced on Executive’s date of termination through such 60th day,
with the balance of the payments paid thereafter on the schedule described above; and (ii) make the lump sum payment specified in Section
6.3(a)(iii) that has not yet been made due to this Section 6.3(b), in the cases of (i) and (ii) subject to any delay in payment required
by Section 6.6.

 

(c) The
benefits provided to Executive pursuant to this Section 6.3 are in lieu of, and not in addition to, any benefits to which Executive may
otherwise be entitled under any Company severance plan, policy, or program.

 

(d) Any
damages caused by the termination of Executive’s employment without Cause or for Good Reason in connection with a Change in Control
would be difficult to ascertain; therefore, the CIC Severance Benefits for which Executive is eligible pursuant to Section 6.3(a) above
in exchange for the Separation Agreement is agreed to by the parties as liquidated damages, to serve as full compensation, and not a penalty.

 

    6

     

    

 

6.4 Cooperation
With the Company After Termination of Employment. Following termination of Executive’s employment for any reason, Executive
shall reasonably cooperate with the Company in all matters relating to the winding up of Executive’s pending work including, but
not limited to, any litigation in which the Company is involved, and the orderly transfer of any such pending work to such other executives
as may be designated by the Company; provided, that the Company agrees that the Company (a) shall make reasonable efforts to minimize
disruption of Executive’s other activities, and (b) shall reimburse Executive for all reasonable expenses incurred in connection
with such cooperation.

 

6.5 Effect
of Termination. Executive agrees that should Executive’s employment be terminated for any reason, Executive shall be deemed
to have resigned from any and all positions with the Company, including, but not limited to, a position on the Board and all positions
with any and all subsidiaries and Affiliates of the Company.

 

6.6 Application
of Section 409A.

 

(a) It
is intended that all of the compensation payable under this Agreement, to the greatest extent possible, either complies with the requirements
of Section 409A of the Code and the regulations and other guidance thereunder and any state law of similar effect (collectively, “Section
409A”) or satisfies one or more of the exemptions from the application of Section 409A, and this Agreement will be construed
in a manner consistent with such intention, incorporating by reference all required definitions and payment terms.

 

(b) No
severance payments will be made under this Agreement unless Executive’s termination of employment constitutes a Separation from
Service. For purposes of Section 409A (including, without limitation, for purposes of Treasury Regulations Section 1.409A-2(b)(2)(iii)),
Executive’s right to receive any installment payments under this Agreement (whether severance payments or otherwise) shall be treated
as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered
a separate and distinct payment.

 

(c) To
the extent that any severance payments are deferred compensation under Section 409A, and are not otherwise exempt from the application
of Section 409A, then, to the extent required to comply with Section 409A, if the period during which Executive may consider and sign
the Separation Agreement spans two calendar years, the severance payments will not begin until the second calendar year. If the Company
determines that the severance benefits provided under this Agreement constitutes “deferred compensation” under Section 409A
and if Executive is a “specified employee” of the Company, as such term is defined in Section 409A(a)(2)(B)(i) of the Code
at the time of Executive’s Separation from Service, then, solely to the extent necessary to avoid the incurrence of the adverse
personal tax consequences under Section 409A, the timing of the severance will be delayed as follows: on the earlier to occur of (a) the
date that is six months and one day after Executive’s Separation from Service, and (b) the date of Executive’s death, the
Company will: (i) pay to Executive a lump sum amount equal to the sum of the severance benefits that Executive would otherwise have
received if the commencement of the payment of the severance benefits had not been delayed pursuant to this Section 6.6(c); and (ii) commence
paying the balance of the severance benefits in accordance with the applicable payment schedule set forth in Sections 6.2 and 6.3. No
interest shall be due on any amounts deferred pursuant to this Section 6.6(c).

 

(d) To
the extent required to avoid accelerated taxation and/or tax penalties under Section 409A, amounts reimbursable to Executive under this
Agreement shall be paid to Executive on or before the last day of the year following the year in which the expense was incurred and the
amount of expenses eligible for reimbursement (and in-kind benefits provided to Executive) during any one year may not effect amounts
reimbursable or provided in any subsequent year. The Company makes no representation that compensation paid pursuant to the terms of this
Agreement will be exempt from or comply with Section 409A and makes no undertaking to preclude Section 409A from applying to any such
payment.

 

    7

     

    

 

6.7 Excise
Tax Adjustment.

 

(a) If
any payment or benefit Executive will or may receive from the Company or otherwise (a “280G Payment”) would
(i) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this Section,
be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then any such 280G Payment
provided pursuant to this Agreement (a “Payment”) shall be equal to the Reduced Amount. The “Reduced
Amount” shall be either (x) the largest portion of the Payment that would result in no portion of the Payment (after
reduction) being subject to the Excise Tax, or (y) the largest portion, up to and including the total, of the Payment, whichever
amount (i.e., the amount determined by clause (x) or by clause (y)), after taking into account all applicable federal, state, and local
employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in Executive’s
receipt, on an after-tax basis, of the greater economic benefit notwithstanding that all or some portion of the Payment may be subject
to the Excise Tax. If a reduction in a Payment is required pursuant to the preceding sentence and the Reduced Amount is determined pursuant
to clause (x) of the preceding sentence, the reduction shall occur in the manner (the “Reduction Method”) that
results in the greatest economic benefit for Executive. If more than one method of reduction will result in the same economic benefit,
the items so reduced will be reduced pro rata (the “Pro Rata Reduction Method”).

 

(b) Notwithstanding
any provision of this Section 6.7 to the contrary, if the Reduction Method or the Pro Rata Reduction Method would result in any portion
of the Payment being subject to taxes pursuant to Section 409A that would not otherwise be subject to taxes pursuant to Section 409A,
then the Reduction Method and/or the Pro Rata Reduction Method, as the case may be, shall be modified so as to avoid the imposition of
taxes pursuant to Section 409A as follows: (A) as a first priority, the modification shall preserve to the greatest extent possible,
the greatest economic benefit for Executive as determined on an after-tax basis; (B) as a second priority, Payments that are contingent
on future events (e.g., being terminated without Cause), shall be reduced (or eliminated) before Payments that are not contingent
on future events; and (C) as a third priority, Payments that are “deferred compensation” within the meaning of Section
409A shall be reduced (or eliminated) before Payments that are not deferred compensation within the meaning of Section 409A.

 

(c) Unless
Executive and the Company agree on an alternative accounting firm or law firm, the accounting firm engaged by the Company for general
tax compliance purposes as of the day prior to the effective date of the Change in Control transaction shall perform the foregoing calculations.
If the accounting firm so engaged by the Company is serving as accountant or auditor for the individual, entity, or group effecting the
Change in Control transaction, the Company shall appoint a nationally recognized accounting or law firm to make the determinations required
by this Section 6.7. The Company shall bear all expenses with respect to the determinations by such accounting or law firm required to
be made hereunder. The Company shall use commercially reasonable efforts to cause the accounting or law firm engaged to make the determinations
hereunder to provide its calculations, together with detailed supporting documentation, to Executive and the Company within fifteen (15)
calendar days after the date on which Executive’s right to a 280G Payment becomes reasonably likely to occur (if requested at that
time by Executive or the Company) or such other time as requested by Executive or the Company.

 

(d) If
Executive receives a Payment for which the Reduced Amount was determined pursuant to clause (x) of Section 6.7(a) and the Internal Revenue
Service determines thereafter that some portion of the Payment is subject to the Excise Tax, Executive agrees to promptly return to the
Company a sufficient amount of the Payment (after reduction pursuant to clause (x) of Section 6.7(a)) so that no portion of the remaining
Payment is subject to the Excise Tax. For the avoidance of doubt, if the Reduced Amount was determined pursuant to clause (y) of Section
6.7(a), Executive shall have no obligation to return any portion of the Payment pursuant to the preceding sentence.

 

		7.	General Provisions.

 

7.1 Notices.
Any notices required hereunder shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be
notified, (b) when sent by electronic mail or confirmed facsimile if sent during normal business hours of the recipient, and if not, then
on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage
prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification
of receipt. All communications shall be sent to the Company at its primary office location and to Executive at Executive’s address
as listed on the Company payroll or (if notice is given prior to Executive’s termination of employment) to Executive’s Company-issued
email address, or at such other address as the Company or Executive may designate by ten (10) days’ advance written notice to the
other.

 

7.2 Severability.
Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Agreement is held to be invalid, illegal, or unenforceable in any respect under any applicable law or rule
in any jurisdiction, such invalidity, illegality, or unenforceability will not affect any other provision or any other jurisdiction, but
this Agreement will be reformed, construed, and enforced in such jurisdiction as if such invalid, illegal, or unenforceable provisions
had never been contained herein.

 

7.3 Waiver.
If either party should waive any breach of any provisions of this Agreement, Executive or the Company shall not thereby be deemed to have
waived any preceding or succeeding breach of the same or any other provision of this Agreement.

 

    8

     

    

 

7.4 Complete
Agreement. This Agreement (including Exhibits A and B), and any other separate agreement relating to equity awards constitute
the entire agreement between Executive and the Company with regard to the subject matter hereof and supersede any prior oral discussions
or written communications and agreements. This Agreement is entered into without reliance on any promise or representation other than
those expressly contained herein, and it cannot be modified or amended except in writing signed by Executive and an authorized officer
of the Company.

 

7.5 Counterparts.
This Agreement may be executed by electronic transmission and in separate counterparts, any one of which need not contain signatures of
more than one party, but all of which taken together will constitute one and the same Agreement.

 

7.6 Headings.
The headings of the sections hereof are inserted for convenience only and shall not be deemed to constitute a part hereof nor to affect
the meaning thereof.

 

7.7 Successors
and Assigns. The Company shall assign this Agreement and its rights and obligations hereunder in whole, but not in part, to any
company or other entity with or into which the Company may hereafter merge or consolidate or to which the Company may transfer all or
substantially all of its assets, if in any such case said company or other entity shall by operation of law or expressly in writing assume
all obligations of the Company hereunder as fully as if it had been originally made a party hereto, but may not otherwise assign this
Agreement or its rights and obligations hereunder. Executive may not assign or transfer this Agreement or any rights or obligations hereunder,
other than to Executive’s estate upon Executive’s death.

 

7.8 Choice
of Law. All questions concerning the construction, validity, and interpretation of this Agreement will be governed by the laws
of the State of Delaware.

 

7.9 Resolution
of Disputes. The parties recognize that litigation in federal or state courts or before federal or state administrative agencies
of disputes arising out of the Executive’s employment with the Company or out of this Agreement, or the Executive’s termination
of employment or termination of this Agreement, may not be in the best interests of either the Executive or the Company, and may result
in unnecessary costs, delays, complexities, and uncertainty. The parties agree that any dispute between the parties arising out of or
relating to the negotiation, execution, performance or termination of this Agreement or the Executive’s employment, including, but
not limited to, any claim arising out of this Agreement, claims under Title VII of the Civil Rights Act of 1964, as amended, the Civil
Rights Act of 1991, the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act of 1990, Section 1981 of the
Civil Rights Act of 1966, as amended, the Family Medical Leave Act, the Executive Retirement Income Security Act, and any similar federal,
state or local law, statute, regulation, or any common law doctrine, whether that dispute arises during or after employment, shall be
settled by binding arbitration in accordance with the Employment Arbitration Rules and Mediation Procedures of the American Arbitration
Association; provided however, that this dispute resolution provision shall not apply to any separate agreements between the parties
that do not themselves specify arbitration as an exclusive remedy. The location for the arbitration shall be the Tampa Bay, Florida area.
Any award made by such panel shall be final, binding and conclusive on the parties for all purposes, and judgment upon the award rendered
by the arbitrators may be entered in any court having jurisdiction thereof. The arbitrators’ fees and expenses and all administrative
fees and expenses associated with the filing of the arbitration shall be borne by the Company; provided however, that at the Executive’s
option, Executive may voluntarily pay up to one-half the costs and fees. The parties acknowledge and agree that their obligations to arbitrate
under this Section survive the termination of this Agreement and continue after the termination of the employment relationship between
Executive and the Company. The parties each further agree that the arbitration provisions of this Agreement shall provide each party with
its exclusive remedy, and each party expressly waives any right it might have to seek redress in any other forum, except as otherwise
expressly provided in this Agreement. By election arbitration as the means for final settlement of all claims, the parties hereby waive
their respective rights to, and agree not to, sue each other in any action in a Federal, State or local court with respect to such claims,
but may seek to enforce in court an arbitration award rendered pursuant to this Agreement. The parties specifically agree to waive their
respective rights to a trial by jury, and further agree that no demand, request or motion will be made for trial by jury.

 

[Remainder of page intentionally left blank.]

 

    9

     

    

 

In Witness
Whereof, the parties have executed this Employment Agreement on the day and year written below, effective as of the Effective
Date.

 

	 	AgileThought, LLC

 

	 	By:	/s/ Laurie Harrison
	 	Name: 	Laurie Harrison
	 	Title:	Chief Legal Officer

 

	 	Signature Date:	September 15, 2020

 

	 	Executive:

 

	 	/s/ Manuel Senderos Fernández
	 	Manuel Senderos Fernández

 

	 	Signature Date:	September 15, 2020

 

    10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]